| dc.contributor.author | De langen, J. | |
| dc.contributor.author | Monkhorst, K. | |
| dc.contributor.author | Skov, B. | |
| dc.contributor.author | Mellemgaard, A. | |
| dc.contributor.author | Dingemans, A. | |
| dc.contributor.author | Speel, E. | |
| dc.contributor.author | Hashemi, S. | |
| dc.contributor.author | Bahce, I. | |
| dc.contributor.author | Van Der Drift, M. | |
| dc.contributor.author | Buettner, R. | |
| dc.contributor.author | Salomon, M. Looijen | |
| dc.contributor.author | Gosney, J. | |
| dc.contributor.author | Postmus, P. E. | |
| dc.contributor.author | Samii, S. | |
| dc.contributor.author | Duplaquet, F. | |
| dc.contributor.author | Weynand, B. | |
| dc.contributor.author | Durando, X. | |
| dc.contributor.author | Penault-Llorca, F. | |
| dc.contributor.author | Finn, S. | |
| dc.contributor.author | Akyurek, N. | |
| dc.contributor.author | Wolf, J. | |
| dc.contributor.author | Bubendorf, L. | |
| dc.contributor.author | Hiemstra, A. | |
| dc.contributor.author | Duin, S. | |
| dc.contributor.author | Marondel, L. | |
| dc.contributor.author | Timens, W. | |
| dc.contributor.author | Schuuring, E. | |
| dc.contributor.author | Pauwels, P. | |
| dc.contributor.author | Smit, E. | |
| dc.contributor.author | Oz, B. | |
| dc.contributor.author | Sorensen, J. | |
| dc.contributor.author | Thunnissen, E. | |
| dc.contributor.author | Lissenberg-Witte, B. | |
| dc.contributor.author | Van den Heuvel, M. | |
| dc.date.accessioned | 2021-03-05T21:46:32Z | |
| dc.date.available | 2021-03-05T21:46:32Z | |
| dc.date.issued | 2018 | |
| dc.identifier.citation | Thunnissen E., Lissenberg-Witte B., Van den Heuvel M., Monkhorst K., Skov B., Sorensen J., Mellemgaard A., Dingemans A., Speel E., De langen J., et al., "Crizotinib-Treated ALK Immunopositive Metastasized NSCLC is Associated with an Unfavorable Prognosis when FISH Negative", JOURNAL OF THORACIC ONCOLOGY, cilt.13, 2018 | |
| dc.identifier.issn | 1556-0864 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.other | av_da80fa42-b886-4b26-9271-b78540fd35f0 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/144055 | |
| dc.identifier.uri | https://doi.org/10.1016/j.jtho.2018.08.542 | |
| dc.language.iso | eng | |
| dc.subject | ONKOLOJİ | |
| dc.subject | SOLUNUM SİSTEMİ | |
| dc.subject | Tıp | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | Göğüs Hastalıkları ve Allerji | |
| dc.subject | İç Hastalıkları | |
| dc.subject | Onkoloji | |
| dc.subject | Klinik Tıp | |
| dc.subject | Klinik Tıp (MED) | |
| dc.title | Crizotinib-Treated ALK Immunopositive Metastasized NSCLC is Associated with an Unfavorable Prognosis when FISH Negative | |
| dc.type | Makale | |
| dc.relation.journal | JOURNAL OF THORACIC ONCOLOGY | |
| dc.contributor.department | Univ Hosp , , | |
| dc.identifier.volume | 13 | |
| dc.identifier.issue | 10 | |
| dc.contributor.firstauthorID | 257844 | |
